Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial

被引：0
|
作者：
Torbicki, A. [1 ]
Mehta, S. [2 ]
Perchenet, L. [3 ]
Pulido, T. [4 ]
Sastry, B. K. S. [5 ]
Sitbon, O. [6 ]
Souza, R. [7 ]
Rubin, L. J. [8 ]
Simonneau, G. [6 ]
机构：
[1] Ctr Postgrad Med Educ, Ecz Otwock, Poland
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Actel Pharmaceut Ltd, Allschwil, Switzerland
[4] Natl Inst Cardiol Ignacio Chavez, Mexico City, DF, Mexico
[5] CARE Hosp, Hyderabad, Andhra Pradesh, India
[6] Hop Univ Bicetre, Serv Pneumol, Paris, France
[7] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil
[8] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [1] EFFECT OF MACITENTAN ON HAEMODYNAMICS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE LONG-TERM, RANDOMISED, PLACEBO-CONTROLLED SERAPHIN TRIAL
    Coghlan, G.
    Torbicki, A.
    Galie, N.
    Rubin, L. J.
    Perchenet, L.
    Simonneau, G.
    THORAX, 2013, 68 : A26 - A26
  • [2] Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
    Sitbon, Olivier
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B. K. S.
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    Simonneau, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] EFFECT OF MACITENTAN ON PULMONARY ARTERIAL HYPERTENSION-RELATED HOSPITALISATIONS: RESULTS FROM THE RANDOMISED CONTROLLED SERAPHIN TRIAL
    Coghlan, G.
    Channick, R. N.
    Rubin, L. J.
    Galie, N.
    Perchenet, L.
    Simonneau, G.
    THORAX, 2013, 68 : A143 - A143
  • [4] Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN)
    Ghofrani, Hossein-Ardeschir
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Mittelholzer, Camilla
    Pulido, Tomas
    Sastry, B. K. S.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    Simonneau, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan
    Galie, N.
    Delcroix, M.
    Ghofrani, H. -A.
    Jansa, P.
    Minai, O. A.
    Perchenet, L.
    Rubin, L. J.
    Sastry, B. K. S.
    Torbicki, A.
    Simonneau, G.
    EUROPEAN HEART JOURNAL, 2014, 35 : 10 - 10
  • [6] EFFECT OF MACITENTAN ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM THE SERAPHIN RANDOMISED CONTROLLED TRIAL
    Youssef, P.
    Galie, N.
    Perchenet, L.
    Rubin, L.
    Simonneau, G.
    Mehta, S.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 31 - 31
  • [7] The Effect Of Macitentan On Long-Term Outcomes In Patients With Pulmonary Arterial Hypertension By Who Functional Class: Data From The Randomized Controlled Seraphin Study
    Channick, R. N.
    Delcroix, M.
    Galie, N.
    Ghofrani, H. A.
    Jansa, P.
    Le Brun, F. O.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B.
    Sitbon, O.
    Souza, R.
    Torbicki, A.
    Rubin, L. J.
    Simonneau, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] Long-Term Survival And Safety With Macitentan In Patients With Pulmonary Arterial Hypertension: Results From The Seraphin Study And Its Open-Label Extension
    Souza, R.
    Pulido, T.
    Channick, R. N.
    Delcroix, M.
    Galie, N.
    Ghofrani, H.
    Jansa, P.
    Mehta, S.
    Mitchell, L.
    Papadakis, K.
    Richard, D.
    Rubin, L. J.
    Sastry, B.
    Sitbon, O.
    Torbicki, A.
    Simonneau, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
    Rogério Souza
    Marion Delcroix
    Nazzareno Galié
    Pavel Jansa
    Sanjay Mehta
    Tomás Pulido
    Lewis Rubin
    B. K. S. Sastry
    Gérald Simonneau
    Olivier Sitbon
    Adam Torbicki
    Neli Boyanova
    Liliya Chamitava
    Claudia Stein
    Richard N. Channick
    Advances in Therapy, 2022, 39 : 4374 - 4390
  • [10] Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
    Souza, Rogerio
    Delcroix, Marion
    Galie, Nazzareno
    Jansa, Pavel
    Mehta, Sanjay
    Pulido, Tomas
    Rubin, Lewis
    Sastry, B. K. S.
    Simonneau, Gerald
    Sitbon, Olivier
    Torbicki, Adam
    Boyanova, Neli
    Chamitava, Liliya
    Stein, Claudia
    Channick, Richard N.
    ADVANCES IN THERAPY, 2022, 39 (09) : 4374 - 4390
12345